Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denny, P.
Right arrow Articles by Lyons, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denny, P.
Right arrow Articles by Lyons, P. A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 4 695-700, Copyright © 1997 by American Diabetes Association


ARTICLES

Mapping of the IDDM locus Idd3 to a 0.35-cM interval containing the interleukin-2 gene

P Denny, CJ Lord, NJ Hill, JV Goy, ER Levy, PL Podolin, LB Peterson, LS Wicker, JA Todd and PA Lyons
Wellcome Trust Centre for Human Genetics, University of Oxford, Headington, U.K.

Currently, 16 loci that contribute to the development of IDDM in the NOD mouse have been mapped by linkage analysis. To fine map these loci, we used congenic mapping. Using this approach, we localized the Idd3 locus to a 0.35-cM interval on chromosome 3 containing the Il2 gene. Segregation analysis of the known variations within this interval indicated that only one variant, a serine-to-proline substitution at position 6 of the mature interleukin-2 (IL-2) protein, consistently segregates with IDDM in crosses between NOD and a series of nondiabetic mouse strains. These data, taken together with the immunomodulatory role of IL-2, provide circumstantial evidence in support of the hypothesis that Idd3 is an allelic variation of the Il2 gene, or a variant in strong linkage disequilibrium.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
M. Lundholm, V. Motta, A. Lofgren-Burstrom, N. Duarte, M.-L. Bergman, S. Mayans, and D. Holmberg
Defective Induction of CTLA-4 in the NOD Mouse Is Controlled by the NOD Allele of Idd3/IL-2 and a Novel Locus (Ctex) Telomeric on Chromosome 1
Diabetes, February 1, 2006; 55(2): 538 - 544.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. M. Chilton, F. Rezzoug, M. Z. Ratajczak, I. Fugier-Vivier, J. Ratajczak, M. Kucia, Y. Huang, M. K. Tanner, and S. T. Ildstad
Hematopoietic stem cells from NOD mice exhibit autonomous behavior and a competitive advantage in allogeneic recipients
Blood, March 1, 2005; 105(5): 2189 - 2197.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Davoodi-Semiromi, M. Laloraya, G. P. Kumar, S. Purohit, R. K. Jha, and J.-X. She
A Mutant Stat5b with Weaker DNA Binding Affinity Defines a Key Defective Pathway in Nonobese Diabetic Mice
J. Biol. Chem., March 19, 2004; 279(12): 11553 - 11561.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M.-L. Bergman, N. Duarte, S. Campino, M. Lundholm, V. Motta, K. Lejon, C. Penha-Goncalves, and D. Holmberg
Diabetes Protection and Restoration of Thymocyte Apoptosis in NOD Idd6 Congenic Strains
Diabetes, July 1, 2003; 52(7): 1677 - 1682.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. Penha-Goncalves, C. Moule, L. J. Smink, J. Howson, S. Gregory, J. Rogers, P. A. Lyons, J. J. Suttie, C. J. Lord, L. B. Peterson, et al.
Identification of a Structurally Distinct CD101 Molecule Encoded in the 950-kb Idd10 Region of NOD Mice
Diabetes, June 1, 2003; 52(6): 1551 - 1556.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. P. L. Chiu, E. Ivakine, S. Mortin-Toth, and J. S. Danska
Susceptibility to Lymphoid Neoplasia in Immunodeficient Strains of Nonobese Diabetic Mice
Cancer Res., October 15, 2002; 62(20): 5828 - 5834.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. J. Roper, R. Z. Ma, J. E. Biggins, R. J. Butterfield, S. D. Michael, K. S. K. Tung, R. W. Doerge, and C. Teuscher
Interacting Quantitative Trait Loci Control Loss of Peripheral Tolerance and Susceptibility to Autoimmune Ovarian Dysgenesis After Day 3 Thymectomy in Mice
J. Immunol., August 1, 2002; 169(3): 1640 - 1646.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
O. Boulard, G. Fluteau, L. Eloy, D. Damotte, P. Bedossa, and H.-J. Garchon
Genetic Analysis of Autoimmune Sialadenitis in Nonobese Diabetic Mice: A Major Susceptibility Region on Chromosome 1
J. Immunol., April 15, 2002; 168(8): 4192 - 4201.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. A. Lyons, N. Armitage, C.J. Lord, M. S. Phillips, J. A. Todd, L. B. Peterson, and L. S. Wicker
Mapping by Genetic Interaction: High-Resolution Congenic Mapping of the Type 1 Diabetes Loci Idd10 and Idd18 in the NOD Mouse
Diabetes, November 1, 2001; 50(11): 2633 - 2637.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Bassiri and S. R. Carding
A Requirement for IL-2/IL-2 Receptor Signaling in Intrathymic Negative Selection
J. Immunol., May 15, 2001; 166(10): 5945 - 5954.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
H. J. Cordell, J. A. Todd, N. J. Hill, C. J. Lord, P. A. Lyons, L. B. Peterson, L. S. Wicker, and D. G. Clayton
Statistical Modeling of Interlocus Interactions in a Complex Disease: Rejection of the Multiplicative Model of Epistasis in Type 1 Diabetes
Genetics, May 1, 2001; 158(1): 357 - 367.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
S. Trembleau, G. Penna, S. Gregori, G. Magistrelli, A. Isacchi, and L. Adorini
Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes
J. Immunol., December 15, 2000; 165(12): 6748 - 6755.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Jordan, P. A. Silveira, D. P. Shepherd, C. Chu, S. J. Kinder, J. Chen, L. J. Palmisano, L. D. Poulton, and A. G. Baxter
Linkage Analysis of Systemic Lupus Erythematosus Induced in Diabetes-Prone Nonobese Diabetic Mice by Mycobacterium bovis
J. Immunol., August 1, 2000; 165(3): 1673 - 1684.
[Abstract] [Full Text] [PDF]


Home page
Genome ResHome page
P. A. Lyons, N. Armitage, F. Argentina, P. Denny, N. J. Hill, C. J. Lord, M. B. Wilusz, L. B. Peterson, L. S. Wicker, and J. A. Todd
Congenic Mapping of the Type 1 Diabetes Locus, Idd3, to a 780-kb Region of Mouse Chromosome 3: Identification of a Candidate Segment of Ancestral DNA by Haplotype Mapping
Genome Res., April 1, 2000; 10(4): 446 - 453.
[Abstract] [Full Text]


Home page
Int ImmunolHome page
Y. Jiang and G. Moller
IL-2 may be a limiting factor precluding lymphocytes from genetically resistant mice from responding to HgCl2
Int. Immunol., May 1, 1999; 11(5): 627 - 633.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-P. Roth, C. Viratelle, L. Dolbois, M. Delverdier, N. Borot, L. Pelletier, P. Druet, M. Clanet, and H. Coppin
A Genome-Wide Search Identifies Two Susceptibility Loci for Experimental Autoimmune Encephalomyelitis on Rat Chromosomes 4 and 10
J. Immunol., February 15, 1999; 162(4): 1917 - 1922.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
L. Geng, M. Solimena, R. A. Flavell, R. S. Sherwin, and A. C. Hayday
Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease
PNAS, August 18, 1998; 95(17): 10055 - 10060.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
L. V. Parijs and A. K. Abbas
Homeostasis and Self-Tolerance in the Immune System: Turning Lymphocytes off
Science, April 10, 1998; 280(5361): 243 - 248.
[Abstract] [Full Text]


Home page
Genome ResHome page
I. A. Eaves, L. S. Wicker, G. Ghandour, P. A. Lyons, L. B. Peterson, J. A. Todd, and R. J. Glynne
Combining Mouse Congenic Strains and Microarray Gene Expression Analyses to Study a Complex Trait: The NOD Model of Type 1 Diabetes
Genome Res., February 1, 2002; 12(2): 232 - 243.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.